Showing 2 posts of 2 posts found.
Sanofi has been hit by generic erosion for key drugs in the second quarter, but the firm is confident it …
European regulators have begun an investigation into a possible risk of cancer in patients taking angiotensin II receptor inhibitors for …
Care Quality Commission appoints Emily Miles as Chief Executive
National survey aims to improve glaucoma care across the UK
Phase 3 trials support expanded use of Dysport for migraine prevention
Roche secures CE Mark for automated latent tuberculosis blood test
ReproNovo Phase 2 fertility study doses first participant